J&J RWVE Hematology
About Johnson & Johnson
Johnson & Johnson is committed to transforming outcomes for patients with complex diseases through innovative science and evidence generation. With more than a century of healthcare leadership, J&J advances medicines across hematology, oncology, immunology, and other therapeutic areas to address pressing unmet needs worldwide. In hematology, J&J has built a broad and growing portfolio and pipeline spanning multiple myeloma, leukemia, and other diseases.
About the RWVE Hematology Team
The Real-World Value and Evidence (RWVE) Hematology team operates at the intersection of science, strategy, and patient care. Its core mission is to advance patient care through the generation of real-world evidence. Across the product lifecycle—from prelaunch evidence planning through post-approval value demonstration—the RWVE team designs and executes real-world studies, develops economic models, and translates findings into actionable insights for patients, providers, payers, and other decision-makers. The team collaborates closely with cross-functional partners, including Medical Affairs, Market Access, Health Economics, and global functions. This collaborative environment exposes fellows to the breadth of evidence-generation activities and decision-making processes within a major pharmaceutical company.
About Rutgers HOPE
The Rutgers University Center for Health Outcomes, Policy, and Economics (HOPE) partners with scientists, clinicians, and stakeholders across academia and healthcare organizations to conduct interdisciplinary research and train future leaders in health economics, outcomes research, real- world evidence, and health policy.
Fellowship Team
Shuchita Kaila, PhD
Fellowship Executive Sponsor
Chintan Dave, PharmD, PhD
Fellowship Director | Rutgers
Xin Yin, PhD
Fellowship Director | J&J
Program and Structure
The HOPE–J&J RWVE Hematology Fellowship is a two-year PharmD fellowship that combines immersive industry experience in hematology with rigorous academic training in outcomes research and real-world evidence (RWE).
Fellows spend two years fully embedded within the J&J Hematology team, gaining continuity, increasing project ownership, and hands-on experience in evidence generation across the product lifecycle. Working alongside experienced J&J scientists, fellows collaborate with cross-functional partners to understand how clinical, real-world, economic, and patient-centered evidence informs strategic decision-making and supports patient care.
Concurrently, fellows complete graduate coursework through Rutgers HOPE and conduct an independent RWE capstone project using large real-world datasets. The capstone is designed for presentation at ISPOR and, when appropriate, submission to a peer-reviewed journal, providing meaningful experience in scientific dissemination.
Potential Areas of Experience
The fellowship exposes fellows to a broad range of evidence-generation activities in hematology. Depending on project needs, fellows can expect to build expertise in the following areas:
- Hematology evidence strategy
- Real-world evidence generation
- Health economics and outcomes research
- Comparative effectiveness research
- Burden of illness and healthcare utilization
- Payer and market access evidence
- Patient-centered outcomes
- Evidence synthesis and literature reviews
- Cross-functional evidence planning
- Scientific communication and dissemination
-
Year 1 provides broad exposure and orientation while progressively increasing the fellow’s contributions to active projects. The fellow is expected to:
- Gain exposure to the J&J organization, therapeutic landscape, and evidence needs
- Support RWE and other evidence-generation projects
- Collaborate with cross-functional partners across the product lifecycle
- Develop skills in study design, data interpretation, project management, and scientific communication
- Complete the majority of Rutgers graduate coursework in RWE
- Design and initiate an independent Rutgers HOPE capstone project using large real-world data
- Participate in HOPE seminars, professional development, and ISPOR activities
-
During Year 2, the fellow progresses toward greater independence, project ownership, and leadership. The fellow is expected to:
- Lead components of hematology evidence-generation projects
- Contribute to evidence strategy and strategic recommendations
- Communicate findings to cross-functional and senior stakeholders
- Deepen quantitative and methodological expertise through applied research
- Complete remaining Rutgers coursework and academic requirements
- Complete and disseminate the capstone through an ISPOR presentation and, when appropriate, peer-reviewed publication
- Mentor and support incoming fellows and other trainees
Application Information
The fellowship is designed for PharmD graduates who are passionate about generating evidence to improve patient outcomes and developing expertise at the intersection of pharmaceutical science, real-world data, and health policy.
Required Qualifications
- PharmD degree completed prior to the fellowship start date
- Strong interest in RWE and the pharmaceutical industry
- Strong written and verbal communication skills
Preferred Qualifications
- Prior research or publication experience
- Programming exposure in SAS, R, or Python
- Coursework or hands-on experience in epidemiology, biostatistics, or health economics
- Clinical exposure in hematology or oncology
Application Materials
- Curriculum vitae (CV)
- Letter of intent describing your interest in real-world evidence
- Academic transcript
Applications and inquiries should be directed to: fellowship_HOPE@pharmacy.rutgers.edu
Applications and questions: fellowship_HOPE@pharmacy.rutgers.edu
